COVID-19 and diabetes in 2020: a systematic review

Farideh A. Javid, Fadi Abdul Waheed, Nisa Zainab, Hamza Khan, Ibrahim Amin, Ammar Bham, Mohammed Ghoghawala, Aneem Sheraz, Radi Haloub

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)


Attempts were made to review the literature on diabetic patients who experience complications when they contract COVID-19, and to determine whether ethnicity and other risk factors play an important role in the development of symptoms and their severity, as well as responding to medications. A literature search was performed using five keywords, namely COVID-19, diabetes, ethnicity, medications, and risk factors between January 2019 and December 2020 using electronic databases such as PubMed, Science Direct, Google Scholar, Springer Link, and Scopus. Forty studies were included. The review indicated that diabetes was a significant risk factor for poorer outcomes and increased mortality associated with COVID-19. There were several risk factors for diabetic patients that increased their likelihood of poorer outcomes associated with COVID-19. These included black and Asian ethnicity, male sex with high BMI. In conclusion, patients with diabetes of black or Asian origin with high BMI, male sex, and older age had an increased risk of poorer outcomes associated with COVID-19. This highlights the importance of considering the history of the patient in prioritising care and treatment.

Original languageEnglish
Article number42
Number of pages14
JournalJournal of Pharmaceutical Policy and Practice
Issue number1
Publication statusPublished - 9 Mar 2023


Dive into the research topics of 'COVID-19 and diabetes in 2020: a systematic review'. Together they form a unique fingerprint.

Cite this